FULTFulton Financial Corporation
- Next report
- No date yet
- none in the next 8 weeks
- Last result
- $0.62Beat
- vs $0.55 expected on Oct 21
- Stock move on it
- +3.64%
- one session
- Typical move
- ±2.3%
- average over 2 reports
- Price
- $23.85
- −0.62% today · $4.74B cap
Past and upcoming reports
2
| Oct 21, 2026 | Sep 30, 2026 | Time not given | $0.55 | Beat$0.62 | +3.64% |
| Jul 14, 2026 | Jun 30, 2026 | Time not given | $0.52 | not recorded | +1.03%2d |
After the report
Jul 14, 2026 report
This covers the Jul 14, 2026 report. The Oct 21, 2026 numbers are in the table above.
FULT rallies above target post-earnings, but overbought RSI flags pullback risk
Fulton Financial reported Q2 2026 earnings on Jul 14. Actual EPS was not disclosed. consensus was $0.52. The stock initially rallied on analyst upgrades, pushing above the average target of $23.67 to $24.79. However, three days post-report, the stock fell 1.59% with RSI at 70.94 (overbought), suggesting profit-taking. No guidance was provided. The next earnings event is listed for Jul 22, which may offer clarity.
Reported against expected
Actual EPS not disclosed. consensus estimate was $0.52. Stock closed at $24.79 on Jul 17, down 1.59% from prior close, after a 3.15% rally on Jul 16. The move suggests market disappointment or profit-taking post initial surge.
Guidance
No guidance provided in available data.
How the stock reacted
Stock closed at $24.79 on Jul 17, down 1.59% from prior close. RSI at 70.94 (overbought). Price is above SMA50 ($21.91) and SMA200 ($20.13).
What changed
Stock surged above analyst target post-earnings, now trading at $24.79 vs $23.67 target.
What the price now assumes
Overbought RSI and proximity to 52-week high suggest near-term pullback risk.
What it means for the business
Upgrade bias limited. monitor next earnings Jul 22 for guidance clarity.
The next one to three months, as we saw it then
Better case25%
Continued EPS growth (TTM +23.1%) and revenue acceleration drive re-rating above $26 target high.
Base case50%
Stock consolidates between $23.50 and $25.50 as overbought condition resolves and earnings uncertainty lingers.
Worse case25%
Overbought correction and disappointing next earnings push stock back toward analyst target of $23.67 or lower.
If you hold it
Hold unless next-quarter revenue misses guidance materially or customer concentration risk worsens.
If you are watching
Add only if next-quarter guidance is reiterated or raised. avoid if guidance is cut or geopolitical risk escalates.
Scenario odds are a judgement, not measured.